Terms: = Leukemia AND HNF1A, HNF1, 6927, ENSG00000135100, TCF1, MODY3, P20823, LFB1
40 results:
1. Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remission.
Yanada M; Yamasaki S; Kondo T; Kawata T; Harada K; Uchida N; Doki N; Yoshihara S; Katayama Y; Eto T; Tanaka M; Takada S; Kawakita T; Nishida T; Ota S; Serizawa K; Onizuka M; Kanda Y; Fukuda T; Atsuta Y; Konuma T
Leukemia; 2024 Mar; 38(3):513-520. PubMed ID: 38129514
[TBL] [Abstract] [Full Text] [Related]
2. Combination of cancer vaccine with CD122-biased IL-2/anti-IL-2 Ab complex shapes the stem-like effector NK and CD8
Shimizu K; Ueda S; Kawamura M; Aoshima H; Satoh M; Nakabayashi J; Fujii SI
J Immunother Cancer; 2023 Jul; 11(7):. PubMed ID: 37400134
[TBL] [Abstract] [Full Text] [Related]
3. BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion.
Jung IY; Narayan V; McDonald S; Rech AJ; Bartoszek R; Hong G; Davis MM; Xu J; Boesteanu AC; Barber-Rotenberg JS; Plesa G; Lacey SF; Jadlowsky JK; Siegel DL; Hammill DM; Cho-Park PF; Berger SL; Haas NB; Fraietta JA
Sci Transl Med; 2022 Nov; 14(670):eabn7336. PubMed ID: 36350986
[TBL] [Abstract] [Full Text] [Related]
4. Decreased tcf1 and BCL11B expression predicts poor prognosis for patients with chronic lymphocytic leukemia.
Liang T; Wang X; Liu Y; Ai H; Wang Q; Wang X; Wei X; Song Y; Yin Q
Front Immunol; 2022; 13():985280. PubMed ID: 36211334
[TBL] [Abstract] [Full Text] [Related]
5. Targeting of the alpha
Cobb DA; de Rossi J; Liu L; An E; Lee DW
J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35210306
[TBL] [Abstract] [Full Text] [Related]
6. EBF1 nuclear repositioning instructs chromatin refolding to promote therapy resistance in T leukemic cells.
Zhou Y; Petrovic J; Zhao J; Zhang W; Bigdeli A; Zhang Z; Berger SL; Pear WS; Faryabi RB
Mol Cell; 2022 Mar; 82(5):1003-1020.e15. PubMed ID: 35182476
[TBL] [Abstract] [Full Text] [Related]
7. PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity.
Funk CR; Wang S; Chen KZ; Waller A; Sharma A; Edgar CL; Gupta VA; Chandrakasan S; Zoine JT; Fedanov A; Raikar SS; Koff JL; Flowers CR; Coma S; Pachter JA; Ravindranathan S; Spencer HT; Shanmugam M; Waller EK
Blood; 2022 Jan; 139(4):523-537. PubMed ID: 35084470
[TBL] [Abstract] [Full Text] [Related]
8. tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALL.
Antoszewski M; Fournier N; Ruiz Buendía GA; Lourenco J; Liu Y; Sugrue T; Dubey C; Nkosi M; Pritchard CEJ; Huijbers IJ; Segat GC; Alonso-Moreno S; Serracanta E; Belver L; Ferrando AA; Ciriello G; Weng AP; Koch U; Radtke F
Blood; 2022 Apr; 139(16):2483-2498. PubMed ID: 35020836
[TBL] [Abstract] [Full Text] [Related]
9. [Silencing DNMT1 Attenuates the Effect of WIF-1 Gene Promoter Methylation on the Biological Behavior of Chronic Myeloid leukemia K562 Cells].
Wu K; Jin Z; Li YX; Li X; Cheng SJ; Li YH; Guo C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Dec; 29(6):1768-1774. PubMed ID: 34893108
[TBL] [Abstract] [Full Text] [Related]
10. Interleukin-10 receptor signaling promotes the maintenance of a PD-1
Hanna BS; Llaó-Cid L; Iskar M; Roessner PM; Klett LC; Wong JKL; Paul Y; Ioannou N; Öztürk S; Mack N; Kalter V; Colomer D; Campo E; Bloehdorn J; Stilgenbauer S; Dietrich S; Schmidt M; Gabriel R; Rippe K; Feuerer M; Ramsay AG; Lichter P; Zapatka M; Seiffert M
Immunity; 2021 Dec; 54(12):2825-2841.e10. PubMed ID: 34879221
[TBL] [Abstract] [Full Text] [Related]
11. Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid leukemia.
Zeidner JF; Vincent BG; Ivanova A; Moore D; McKinnon KP; Wilkinson AD; Mukhopadhyay R; Mazziotta F; Knaus HA; Foster MC; Coombs CC; Jamieson K; Van Deventer H; Webster JA; Prince GT; DeZern AE; Smith BD; Levis MJ; Montgomery ND; Luznik L; Serody JS; Gojo I
Blood Cancer Discov; 2021 Nov; 2(6):616-629. PubMed ID: 34778801
[TBL] [Abstract] [Full Text] [Related]
12. Increased frequency of TIGIT
Brauneck F; Haag F; Woost R; Wildner N; Tolosa E; Rissiek A; Vohwinkel G; Wellbrock J; Bokemeyer C; Schulze Zur Wiesch J; Ackermann C; Fiedler W
Oncoimmunology; 2021 Jun; 10(1):1930391. PubMed ID: 34211801
[TBL] [Abstract] [Full Text] [Related]
13. Regnase-1 suppresses TCF-1+ precursor exhausted T-cell formation to limit CAR-T-cell responses against ALL.
Zheng W; Wei J; Zebley CC; Jones LL; Dhungana Y; Wang YD; Mavuluri J; Long L; Fan Y; Youngblood B; Chi H; Geiger TL
Blood; 2021 Jul; 138(2):122-135. PubMed ID: 33690816
[TBL] [Abstract] [Full Text] [Related]
14. Protein kinase C-β-dependent changes in the glucose metabolism of bone marrow stromal cells of chronic lymphocytic leukemia.
von Heydebrand F; Fuchs M; Kunz M; Voelkl S; Kremer AN; Oostendorp RAJ; Wilke J; Leitges M; Egle A; Mackensen A; Lutzny-Geier G
Stem Cells; 2021 Jun; 39(6):819-830. PubMed ID: 33539629
[TBL] [Abstract] [Full Text] [Related]
15. Human CXCR5
Hofland T; Martens AWJ; van Bruggen JAC; de Boer R; Schetters S; Remmerswaal EBM; Bemelman FJ; Levin MD; Bins AD; Eldering E; Kater AP; Tonino SH
Eur J Immunol; 2021 Mar; 51(3):703-713. PubMed ID: 33098668
[TBL] [Abstract] [Full Text] [Related]
16. Risk factors associated with suicide among leukemia patients: A Surveillance, Epidemiology, and End Results analysis.
Yu H; Cai K; Huang Y; Lyu J
Cancer Med; 2020 Dec; 9(23):9006-9017. PubMed ID: 33022890
[TBL] [Abstract] [Full Text] [Related]
17. Risk-associated alterations in marrow T cells in pediatric leukemia.
Bailur JK; McCachren SS; Pendleton K; Vasquez JC; Lim HS; Duffy A; Doxie DB; Kaushal A; Foster C; DeRyckere D; Castellino S; Kemp ML; Qiu P; Dhodapkar MV; Dhodapkar KM
JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32692727
[TBL] [Abstract] [Full Text] [Related]
18. Histone Modifications Regulate the Developmental Expression of Human Hepatic UDP-Glucuronosyltransferase 1A1.
Nie YL; Meng XG; Liu JY; Yan L; Wang P; Bi HZ; Kan QC; Zhang LR
Drug Metab Dispos; 2017 Dec; 45(12):1372-1378. PubMed ID: 29025858
[TBL] [Abstract] [Full Text] [Related]
19. Prostaglandin E1 and Its Analog Misoprostol Inhibit Human CML Stem Cell Self-Renewal via EP4 Receptor Activation and Repression of AP-1.
Li F; He B; Ma X; Yu S; Bhave RR; Lentz SR; Tan K; Guzman ML; Zhao C; Xue HH
Cell Stem Cell; 2017 Sep; 21(3):359-373.e5. PubMed ID: 28844837
[TBL] [Abstract] [Full Text] [Related]
20. Down's Syndrome and Triple Negative Breast Cancer: A Rare Occurrence of Distinctive Clinical Relationship.
Dey N; Krie A; Klein J; Williams K; McMillan A; Elsey R; Sun Y; Williams C; De P; Leyland-Jones B
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590426
[TBL] [Abstract] [Full Text] [Related]
[Next]
